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this study was to determine whether t 
othelium-dependent vasodilation evok 
r;a between the curouary and forearm 
Administration of t.-arginine, a substrate in the 
nitric oxide, may stimulate the 
. Seven patients with nomml coronaty angiegrams and 
mild coronary artery disease and hypertension under- 
also increased forearm tylcho 
increases in ~~ro~a~ an were 
less in patients with c sease tb~n Ml con 
patients. Intracoronary infusion of 1..rrgininc at 50 mg/min did 
not alter responses of ?he large coronary artery diameter or 
coronary blood flow to a~tylcboline in either group. fn contrast, 
1..arginine at 10 mglmin significantly (p < 0.W augments the 
forearm blood low response to acetylcholine (4 to 24 
a similar extent in the two groups. 
went coronary arteriography and an intracoronary Doppler cath- 
eter technique, and the diameter of the large epicardial coronary 
artery and coronary blood low were measured. Forearm blood 
flow was measured by use of a strain gauge plethysmograpb. 
lures in humans. It is 
induced coronary and 
&s&r. Before L-aginine administration, acetylcholine (1 to 
30 Clglmin) increased coronary blood flow with modest vasocon- 
strictton of a large coronary artery. Acetyleholine (4 to 24 &mitt) 
~xu=onaty artery disease and hypertension may not be related to a 
limited availability of t.-erginiue. 
Retxnt studies (l-7) in animals and humans kavc detnonstrated 
that the vascular endothelium plays an important role in the 
regulation of regional blood Row by releasing endothelium- 
derived relaxing factors It has been shown (8) that nitric oxide is 
a major cqmponcnt of endothelium-derivtd relaxing factor and is 
synthesized from an amino acid, r.-arginine, in cndothelial cells. It 
has also been shown (1,2) that the endotheliurn-dependent vaso- 
dilator mechanisms differ among the vascular beds and species. 
vasodilation and that r_-arginine at low doses augmented 
cndothelium-dependent forearm vasodilation evoked with acc- 
tylcholinc in healthy human subjects. These findings suggest 
that administering an increased concentration 0: the substrate 
of nitric oxide synthesis, t,-arginine, facilitates release of nitric 
oxide in the peripheral vasculature of healthy humans. 
It has been reported (9,lO) that intravenous administration 
of r.-@nine, a substrate of nitric oxide production, reduced 
arterial pressure, possibly by means of vasodilation of periph- 
eral resistance vessels in humans. We showed (11) that intra- 
arterial infusion of r.-arginine at large doses caused forearm 
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In contrast, Drexler et al. (12) demonstrated that intracoro- 
nary infusion of r.-arginine did not alter vasomotor responses 
of large and resistance coronary arteries to acetylcholine in 
patients with no hypercholesterolemia. These previous findings 
may suggest that the effect of r_-arginine on acetylcholine- 
induced vasodilation may differ between the peripheral and 
coronary vasculature in humans. However, whether the effect 
of L-arginine on endothelium-dependent vasodilation differs 
between the peripheral and coronary vasculature in humans 
has not been determined because no study has examined its 
effect in the two vasculatures in the same subjects. 
I 
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We (S-7) and other investigators (12-19) have demon- 
strated that hypercholesterolemia as well as other risk factors 
for atherosclerosis are associated with impaired endothelium- 
dependent vasodilation in the peripheral or coronary vascula- 
ture in animals and humans. It has been shown (12,20-25) that 
defective endothelium-dependent vasodilation caused by low- 
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density lipoprotein or hypcrcho CStCd3lliil is rcvcrscd by 
supplementation with L-arginine. On the basis of these prcvi- 
ous results, it is proposed that the limited availability of 
e-arginine for synthesis of cndothclium-derived nitric oxide or 
an cnhanccd inactivation of cndothclium-dcrivcd nitric oxide 
is a C~USC Ijf dcfcctivc cndorhclium-d~pcndc~~t vasodilation in 
hypcrcholcstcrt)leIl~ia or an early stage of athcrosclcrosis 
(26-30). However, it is not known whcthcr local administra- 
tion of I.-arginine improves endothelium-dependent vasodila- 
tion in patients with mild coronary artery disease or risk factors 
other than hypercholesterolemia. 
We aimed to determine whether the effect of local admin- 
istration of I_-arginine on endothelium-dependent vasodilation 
evoked with acetylcholine differs be’:Neen the coronary and 
forearm vasculatures in humans. In addition, we examined 
whether impaired acetylcholine-induced vasodilation in pa- 
tients with coronary artery disease is related to a limited 
availability of L-arginine. 
Study patients. The study included 14 patients undergoing 
diagnostic coronary arteriography for investigation of coronary 
artety disease who were classified into two groups on the basis 
of coronary arteriographic findings (Table I). Group 1 (control 
patients with normal coronary angiograms) included seven 
patients who had atypical chest pain and angiographically 
normal coronary arteries without wall irregularities in any of 
three major coronary arteries. Coronary arteriography was 
done in these patients to exclu 
pasm as a cause of atypical 
ai exercise test an4 negative 
2 (patients with coronary artery 
) included swx patients with lumen irregularities 
stenosis) in the left anterior descending coronary 
artery. Three patients had mild, and four had significanr, 
osis (5407~ and >76% iameter stenosis, respecGvely) in 
flex or right coronary artery. 
Coronary and forearm blood flow re- 
ere measured in each patient. Antiangina 
and antihypertensive medications (Table 1) were discontinued 
at least 24 h before the coronary or forearm blood flow stu ;ly. 
Cardiac catheterization was performed with patients ia the 
fasting state after administration of 5 mg of oral diazepam. 
After completion of diagnostic coronary arteriography, the 
lary blood ROW study was carried out by one investigator 
.) who used an intracoroaary Doppler catheter technique 
re or after the coronary blood 
w study was ~c~formed by two 
wirh use of a strain gauge 
plethysmograph. These two studies were done within 5 
The study prolocol was approved by the in~~itat~oaal co 
tee on human research, and written informed consent was 
obtained from each patient. 
Qwa~tita~ive cQr~~a~ asteriu y. The diameter and 
cross-sectional arca at the proximal scgmcnt of left anterior 
dcsccnding coronary artery were determined using a validated 
cincvideodensitometric analysis system, as previously de- 
scribed (S-7). After selection of the view that allowrxd the best 
visualization of the left anterior descending coronary artcry, 
coronary iulgiq.ylls wcrc rccordcd with a Sicmens cincangio- 
graphic system. Thr angle of view and the disrancc from the 
X-ray focus Lo lhc object and that from [he object to the image 
intensifier were kept constant during the study. 
An end-diastolic frame was selected on a cineprojcctor, and 
the image of the arterial segment of interest was digitized and 
analyzed wifh the videodensitometric analysis system. The 
diameter of the segment of interest (2 mm in length) was 
measured three times, and the average value was used for 
analysis. Two or more branch points were determined to allow 
asscssmcnt of serial changes in the diameter of the same 
arterial site in response to drugs. The size of a Judkins catheter 
was used for calibrating the arterial diameter in millimeters. 
Measurements of coronary blood fbw veracity and blood 
flow. A 8F dngioplasty-gui.ling catheter was introduced into 
the left main coronary artery by a femoral approach. A 3F 
Doppler flow velocity catheter (moJ:l DC-201, Millcb Instru- 
merits) was introduced into the pccrximal left anterior descend- 
ing coronary artery. Blood Ilow velocity signals were obtained 
using a Millar DC-101 velocimeter. Coronary blood flow was 
estimated from the product of the mean cororlmy blood flow 
velocity and the cross-sectional area of Ihc proximal left 
anterior descending coronary artery segment distal to the tip of 
the Doppler catheter, as previously described (S-7). 
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Table 2. Vasomotor Response of the Large Epicardial Coronary Artery Diameter to Acetylcholine 
Before and During L-Arginine Infusion 
Aeetylcholine (&min) 
Baseline 1 3 10 30 
Coronary Artery Diameter (mm) in Control Patients With a Normal Coronary An&gram 
Before L-arginine infusion 2.6 t 0.2 2.7 + 0.3 2.1 T!z 0.4 2.6 lr 0.4 2.3 -c 0.4* 
During L-arginine infusion 2.6 2 0.6 2.8 k 0.7 2.6 t 0.5 2.6 + 0.5 2.3 2 OS 
Coronary Artery Diimctc, (mm) in Patients With Coronary Artery Disease 
fkfore L-arginine infusion 3.6 t 0.7 2.6~1.0 . 2.5 r 0.9 2.6 z 0.8 2.4 + 1.0’ 
During barginine infuskfl 2.8 c 0.8 2.7 + 0.8 2.6 c 0.7 2.5 f 0.9 2.4 2 0.7* 
*p < 0-G WrlSus eontrot value. Data presented are mean value 2 SD. 
After completion of the diagnostic catheterization, the 
following studies were performed: 1) Papaverine (10 mgB ml) 
was injected th the lumen of the 
2) Acetylcholine ded doses of I, 3,10 a 
2 min at each dose) was infused through the Doppler catheter. 
from the effect of acetylcholine, L-arginine 
infused through the guiding catheter. Ten 
@choline infusion was repeated while L- 
arginine was simultaneously infused. We selected this dose of 
L-argininc for the coronary blood flow study because at doses 
of rlM;) mg/min, L-arginine increased basal coronary blood 
the preliminary studies (data not shown). 
suremenb OP forearm blood flow. Studies were done 
e subjects in the supine position. Forearm blood flow 
was measured by use of a mercury-in-silastic strain gauge 
plethysmograph and the venous occlusion technique (1 lJ4). 
The strain gauge was placed -5 cm below the antecubital 
crease. The pressure in the venous occlusion or congesting cu8 
was 40 mm Hg. Circulation to the hand was arrested during 
determination of forearm blood flow by inflating a cuff arouad 
the wrist to a pressure that was suprasystolic. Forearm blood 
flow was taken as the average of at least four flow measure- 
ments made at E-s intervals. The brachial artery was rannu- 
la&d with a catheter for drug infusion and measure- 
ment of arterial pressure. Arterial pressure was recorded by 
connecting the arterial line to a pressure transducer with a 
three-way stopcock. 
After the placement of a cannula and a strain gauge 
plethysmograph, at least IS min was allowed for the subjects to 
become accustomed to the study conditions before the begin- 
ning of the protml. The arterial line was kept open by 
infusing heparinized saline solution before drug infusion. 
We examined forearm vasodilating responses to intraarte- 
rial infmions of acetylcholine and sodium nitroprusside. Ace- 
tylcholine (4,8, 16 and 24 @min) and sodium nitroprusside 
(0.2,0.4,0.8 and 1.6 &min) were infused for 2 min at each 
dose. The order of the series of drug infusion was alternated. 
Forparm blood flow was measured continuously in the ipsilat- 
era1 arm during drug infusion. Because forearm blood flow 
ceached a steady state by 1 min after starting infusion of each 
drug, we used the last 1 min of measurements during drug 
infusion of each dose for analysis. After recov 
inf~lsion of L-ar~iaiae at 10 rn~rn~n was start 
after starting infusion of b-arginine, forearm vasodi~at~~~ re- 
sponses to acetylcholine and sodium aitropr~ss~de were exam- 
ined while t_.-arginine was simultaneously infused. We selected 
this dose of t_-arginine for the forearm blood 
because infusion of L-arginine at doses of ~20 
creased, but 10 mgimin did not increase basal fo 
sinus vein, and blood was withdrawn at the baseline condition 
and 10 min after intracoronary L-arginine infusion at 50 mg/ 
min for determination of plasma arginine levels in coronary 
sinus blood. Q~~rin~ the forearm blood flow y, venous 
blood was drawn from an antecubital vein of ipsilateral 
forearm before and 10 min after L-arginine at 10 mg/min. 
Plasma argininc levels were measured with an amino acid 
analyzer at a commercial laboratory (SRL. Tokyo, Japan). 
S~tist~~l analysis. Data are expressed as mean value +- 
SD, except for the figures. For comparisons of the dose- 
response relation with acetylcholine or sodium nitroprusside 
before and after t,-arginine, two-way analysis of variance for 
repeated measures was used. Serial changes in blood flow and 
hemodynamic variables in response to drugs at the graded 
doses were compared using one-way analysis of variance. 
Paired data were compared by Student t test; p < 0.05 was 
considered significant. 
tient characteristics. shows clinical characteris- 
tics of the study patients. Mean ages (p = 0.02) and incidence 
of arterial hypertension (p < 0.01) were significantly higher in 
patients with coronary artery disease than in control patients. 
Mean serum total cholesterol level did not differ between the 
two groups. None of the patients in either group had diabetes 
mellitus. 
Effects arginine on coronary artery diameter and 
coronary b flow. Table 2 shows the changes in the diam- 
eter of the large epicardial coronary artery, arterial pressure 
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e 1. Acetylcho~~ne-induced increases in coronary UL 300 
flow before and during infusion of L-arginine (L-AC) 
in control patients and ients with coronary artery disease 
(CAD). The percent reases from the baseline value 200 
(expressed as mtt%) a ata are mean value 2 
SE. Pa.05 
a; 100 
I LAG (-) 1 IL-AG (+) - 
~~ 
0 
-AG (-1 
-AG (+) I NS 3 
0 PCO.05 
Control 1 3 10 30 
Aeotylc~oti~e (pglmin) 
and heart rate in response to intraco~ona~y infusion of acetyl- 
c~(~~i~c before and daring s~~~alt~~co~s j~~f~~sio~ of I.-aq$nine 
iameter (2.6 IL 0.2 and 
mm, p = NS), arterial pressure (82 + 7 and 90 + 
< 0.05) and heart rate (69 -f 7 and 74 + 12 beats/ 
r between control patients and 
tients with coronary artery disease, respectively. 
r-arginine, the lsrge coronary artery diameter shgh 
significantly decreased (p -=z 0.05) at the high dose (30 &mm) 
of acetylcholine in control patients as well as in patients with 
coronary artery disease. The responses of the large coronary 
artery diameter to acetylcholine were similar between the two 
groups. The infusion of L-arginine did not alter the baseline 
arterial diameter, arterial pressure, heart rate or their re- 
sponses to acetylcholine in either group. 
Acetylcholine significantly (p < 0.01) increased coronary 
blood flow in a dose-dependent manner in the two groups (Fig. 
1). Before t.-arginine infusion, the percent increases in coro- 
nary blood flow evoked with acetylcholine were significantly 
< 0.05) in patients with coronary artery disease than 
in control patients. The percent increase in coronary blood 
flow evoked with papaverine was comparable between the two 
groups (481 + 30% in group I, 446 + 49% in group 2, 
I.-Arginine infusion did not alter the coronary bl 
heart rate (64 + 5 beats/min in control patients, 64 I!I 2 beatslmin 
in patients with coronary artery disease) at the forearm blood flow 
study were comparable to those at the coronary blood flow study 
(Table 3). Figure 2 shows the percent increase in forear,n blood 
flow evoked with acetylcholine before and during L-arginine 
infusion. Before L-arginine, the dose-dependent increases in 
forearm blood flow evoked with acetylcholine were significantly 
smaller (p < 0.01) in patients with coronary artery disease than in 
control patients, but the forearm blood flow responses tosodium 
nitroprusside w re comparable b tween the two groups (Table 4). 
Infusion of L-arginine at 10 mglmin did not alter basal arterial 
pressure and heart rate or their responses LO acetylcholine or
nitroprusside. r_-Arginine significantly augmented (p < 0.01) the 
forearm blood flow responses toacetylcholine in the two groups, 
although it did not alter the forearm blood flow responses to
sodium nitroprusside in either group. During L-arginine infusion, 
Table 3. Forearm Blood Flow Response to Acetylcholine Before and During L-Arginine Infusion 
Acetylcholine (pdmin) 
Baseline 4 8 16 28 
Forearm Blood Flow (ml/min per I00 ml) in Control Patients With a Normal Coronary Angiogram 
Before L-arginine infusion 4.4 ?I 1.5 9.2 + 5.3’ 18.8 I! 10.1’ 29.6 2 19.7” 33.0 t 19.9* 
During L-argininc infusion? 3.Y r I.2 19.0 + 11.3* 30.3 + 20.1* 37.7 2 23.3’ 36.0 + 24.‘)” 
Forearm Blood Flow (mlhin per 100 ml) in Patients With Coronary Artcry Disease 
Before L-arginine infusion 2.7 -c I.1 5.3 2 3.s* 8.7 + 5.6’ 13.3 4 w II.8 + Y.6* 
During L-arginine infusion? 2.9 2 I.1 1.4 r 4.3* 12.2 ?r 8.1” 21.3 ?r 9.3’ 22.5 + 14.0* 
*p < 0.01 versus control value. tp < 0.01 versus before L-arginine by analysis of variance. Data presented are mean 
value 2 SD. 
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0 
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tt pa01 
ac~tylcholinc-induced incrcnscs in forcarm blood flow were still 
smaller (p < 0.01) in puticnts with coroniuy iWtWy di.sciIX than in 
control pticnts. 
PIastna wwginine kvels. The basal plilsmu argininc lcvcl 
in the coronary sinus w;IS I1 I 21 22 nmol/ml in control pitticnts 
(n = 6) and 100 .I? 23 nmol/ml in patients with coronary artcry 
discasc (n = 6, p = NS). Intrncoronary infusion of I.-;qininc 
ilt 50 mg/min incrcuscd the plusma argininc ICVCI in the 
coronary sinus from 106 9 10 to I.063 ~fr 257 nmol!nrl (p < 
0.01) (n = 4 [3 patients with cornnary urtcv discrtsc and I 
control patient]), 
Intrudrtcrial infusion of I.-iqinino ibt IO ni@min increilscd 
the plasmi argininc IOWA in iln ipsilMcrid imtccuhitid win from 
I10 2 IO to 1,140 rt: 2% nmollml (p i 0.M) (n = J [:! control 
puticnts and 2 ptlticnts with coronary ;rrtcq discibscl). 
The major findings of this study iire thiit intracoronary 
t.-@nine 81 51) mplmin did not itltcr ucctylcholinc-induccJ 
changes in the diumctcr of lap cpicnrdinl coronary artery or 
wrotwy blood Aow in either control patients or patients with 
JAW Vol. 24, No. 4 
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Agure 2. Acetylcholinc-induced increases in fore- 
arm blood How before and during infusion of 
L-@nine (L-AG) in control patients and patients 
with coronary artery disease (CAD). The percent 
increases from the baseline value (expressed as 
100%) are presented. Data are mean value -C SE. 
**p < 0.01 hcforc and iifter L-@nine infusion by 
analysis of V;briiUlCC. SSp < 0.01 bClWCCn patients 
with and without ctlromlq urteq discnsc hy m@sis 
Of WlhlCC. 
coronary artcry discitsc. whcrcos ~~tr~~~rtcrii~~ infusion of I.- 
arginine iit 10 mg/min i~u~~lcntcd ncetylclloline-illduccd in- 
crcascs in forearm blood flow to a similar extent in the two 
groups. These results indicate that the cffcct of t.-argininc on 
cndothelium-dcpcndent v~s~di~~~t~l~~ with ~cctylc~~~lir~c crs 
the cor~miny imd forearm viisculat 
s of mwginine cm ~cety~cho~ifle-~ 
vasomotion. In patients with and without coronary artery 
discasc. ncctylcholinc did not cause vasodilation of large 
oronary artcv, and the drug at the high dose 
st but si~~~ificilnt vitsoconstriction. The degrees of 
vxalconstriction Of lill$C c~~r~~~~~~ artery W&cd with ilCQl- 
choline wcrc not statistkdly ditfcrcnt bctwccn the two groups. 
The results arc consistent with the previous findings. because it 
has been shown that intrxoronary infusion of acctylcholinc 
citUsCS vssoconstriction of ~~n~io~r~phic~l~y normal segments 
of lqc epicardial coronary artcries in patients who have 
risk factors for coronary atherosclerosis or in patients with 
athcrosclcrotic lesions elsewhere in other coronary arteries 
(5,6,13,31-33). Our control patients had risk factors, such as 
&c 2250 y&s, smoking or &Id hypcrcholcstcrolemi;I, all of 
Table d Furcrrm Blood Fluw Response to Sudium Nitmprusside Before ilnd During 
L-Aginine Infusion 
Sodium Nitroprusside (~.gGa) 
BaseIke 0.2 0.4 0.X I.6 
Forearm Bloud Row (mlimin per 11)(1 ml) in Control Patients With a Normal Coronury Angiogram 
Before I.-aginine infusion 4.7 c I.1 5.6 ? 1.x 8.0 + 2.2* IO.5 + 2.8” 14.0 z3.Y* 
During I.-arginine infusion 4.h i: 1.2 6.4 2 2.3 7.6 f 3.3‘ x.3 ? 3.4* 12.x + s.x* 
Forearm Bkxnl Flow (mumin per ill0 ml) in Patients With Coronary Artery Disease 
Before t.-arginine infusion 2.7 2 I.1 5.3 f 3.8 8.1 2 5.b* 13.3 r 8.5* 11.8 2 Y.6’ 
During L-arginine infusion 3.6 +_ 1.x 4.x 5 I.9 5.5 z 1.q 7.3 f 2.3* 10.0 + 3.0* 
*p < 0.05, in < 0.01 versus control value. Data presented are mean value 2 SD. 
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which were associated with attenuated en 
v~sod~~ati~~ of large coron 
de~e~~~e~t manner in MS imd in paticnt~ with 
coronary artery disease. ncreases in coronary blood 
flow evoked with acetyl 
artery disease than in control patients 
response lo ~~~p~~v~r~~~~ was similar 
These results are also consistent with the previous findi 
the increase in c~~r(~~~a~y blood flow evoked with acetylcholine is 
impaired by the presence of coronary risk factors and upstream 
~~t~lcr~~scler(~tic lesions (5,6,12). 
Our results de~ii~~llstr~~tc~l tlliht i~~f~lsi~~~~ of I.-arginine ilt 50 
~~~g/li~ili did t101 alter responses of large epicardial coronary 
iHWy TO ilCCtylCllOh! in either C0ntrd piltiClltS or 
with COlolliUy iNtCry disease. This lit1 
Ihill Of DR!XlCr Cl ill. (12). WhO Sh~WCd tllnt illllXCOluil;l~y 
I.-nrginine ill IO0 ~nrol/min IMI no clfcct on vasomolor 
responses of the large Cl)iCildiill CoWWl): artery to Xetylcho- 
lint (0.036. 0.30 and 3.6 &min) in patients with ild without 
hypcrcholesterolemia. The dose of I.-arginine that we infused 
into the coronary artery (SO mgfmin) was similar to that used 
by Drcxler ct al. Dubois-l&de et al. (34) demonstrated that 
intracoronary I.-argininc a: 25 mg/min attenuated vasoconstric- 
lion of the large coronary artcries evoked with acetylcholinc at 
higher doses ( IO ” and 5 X IO ” al~~~/l~ter) in patients who had 
hyperchoiesterolcmia and dilluse lumen narrowing in the study 
artery. They suggested that less vasoconstriction of the large 
coronary artery evoked with acctylcholine after t_-argininc 
might have resulted from an increased release of endothclium- 
derived relaxing factor by L-argininc. Tho difference in pa- 
tients, such as the degree of athcrosclcrotic chimgcs, the strum 
cholcstcrol level or the doses of ilCCtylChOlille or I.-argininc 
used, might have accounted for the dilferent results between 
these studies. 
Our results also indicated that t_-arginine at SO mg/min did 
not improve the coronary blood flow response to acetylcholinc 
in either control patients or patients with coronary artery 
disease. Of note is that infusion of r.-argininc into the brachial 
artery at IO mg/min signifcantly augmented forearm blood 
flow responses to acetylcholine in the same patients. It is 
unlikely that the dose of intracoronary t_-arginine was inade- 
quate, because the magnitude of the increase in plasma 
arginine levels in coronary vein during intracoronary infusion 
of t-arginine WCS identical to that in antecubital vein during 
infusion of t_-arginine to the brachial artery. 
Our results showing no effect of L-arginine on the coronary 
blood flow response to acetylcholine differ from those of 
Drexlcr et al. (12) who demonstrated that intracoronary 
administration of t_-arginine significantly improved the coro- 
nary blood flow response to acetylcholine in patients with 
hypercholesterolemia. Drexler et al. concluded that L-arginine 
improved endothelial dysfunction at the level of resistance 
vessels by increasing the production of endothelium-derived 
nitric oxide. A major difference between our study and the 
rexler et al. (12) is that exler et al. compared the 
e&t of t.-arginine with and without hyper- 
c~io~este~o~emia, w mpared its effect between 
patients with and without coronary artery disease. Importantly, 
scan serum cholesterol level did not differ between our 
Control patients and patients with coronary artery disease. 
t the beneficial effects of L-arginine on 
coronary vasodilation evoked with 
fined to the coronary microcirculation 
in patients with hypercholesterolemia. In this study, the coro- 
nary blood flow response to acetylcholine after supple ;lenta- 
tion with r-arginine was still less in patients with coronaiy 
artery disease than in control patients, which suggests that the 
mecl~~~iiisnis of impaired acetylcholinc-induced vasodilation of 
thC rcsistimcc COrO~~il~~ illI~ly in the presence of an upstream 
coronary arlcry lesion arc not related to ;I limited availability of 
I.~il~~i~lillS. 
It hS h!Cll ~lSSUlllCd thill ilCCtylChOlil1~ increases coronary 
blood flow largely by the muscarinic reCCptor-medintCd rcletaC 
of endothclium-derived relaxing factors such as nitric oxide in 
humans (35,36). This assumption is based on the finding that 
the acctylcholine-induced increase in coronary blood flow was 
attcnuatcd by metbylene blue (36). which inhibits the cyclic 
guanosinc monophosphate pathway. However, Lefroy ct al, 
(37) found that the coronary blood flow response to acetylcbo- 
line, which was assessed indirectly by the changes in oxygen 
saturation of coronary venous blood, was not altered by 
intraCOr0niiry infusion of No-monomethyl-r_-argiirinc, an in- 
hibrtor of nitric oxide synthesis, suggesting that acctylcholinc- 
induced vasodilation of the resistance coronary artery may nor 
he mediated by endothclium-derived nitric oxide. If so, it is 
possible that acetylcholinc-induced increases in coronary 
blood flow arc not altcrcd by I.-argininc supplcmcntation, as 
prcscnted in this study. Further studies are needed to elucidate 
the mechanism involved in the acetylcholine-induced vasodi- 
lation of the coronaty vascular bed in humans. 
Effects of L-arginine on the ace~~~~Q~iae_~ 
vasodilation. The forearm blood flow response to acetylcho- 
line was attenuated significantly more in patients with coronary 
artery disease than in control patients, whereas the forearm 
blood flow response to sodium nitroprussidc was comparable 
between the two groups. These findings may be accounted for 
by the presence of risk factors such as hypertension, which arc 
known to be associated with impaired endothelium-dependent 
vasodilation in the human forearm (14-16). Hypertension was 
present in six of seven patients with coronary artery disease but 
in none of the control patients. 
The results of the present study indicate that infusion of 
L-arginine at IO mg/min into the brachial artery signifcantly 
augmented the forearm blood flow response to acelykhohne 
but did not augment the response to nitroprusside in control 
patients as well as in patients with coronary artery disease and 
hypertension. These results suggest that L-arginine facilitated 
nitric oxide synthesis in the endothelial cells of forearm 
resistance vessels and thus augmented the forearm blood flow 
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response to acetylcholine in these patients. The magnitude of 
t.-arginine-induced augmentation of forearm vasodiiation 
evoked with acetylcholine was similar between the hv0 groups, 
and after t_-arginine, the increases in forearm blood flow with 
acetylcholine were still smaller in patients with coronary artery 
disease than those in control patients (Fig. 2). Our results 
dilfer from those of Panza et al. (38), who demonstrated that 
acetylcholine-induced forearm vasodilation was not altered by 
intraarterial infusion of L-arginine at 40 pmol/min (a similar 
dose to that used in this study) in hypertensive patients. The 
different results between our study and the study of Panza et al. 
(38) may have resulted from different patients studied (pa- 
tients with mild hypertension [mean blood prcssurc 90 mm Hg] 
in this study vs. patients with long-lasting hypcrtcnsion 
[ I48 mm Hg] treated for ~5 years in the study of Panza ct al. 
[3X1). These results su cst that the mechanism responsible for 
the impaired endothclium-dependent forearm vasodilation in 
our patients with coronary artery disease and hypertension 
may not bc r&ted to a limited availability of t_-argininc. 
Conelusions. It is clear from the results of this study that 
the effect of local infusion of t.-arginine on acctylcholinc- 
induced vasodilation differs between the coronary and forearm 
vasculatures in both control patients and in patients with 
coronary artery disease and hypertension. These results are 
consistent with the suggestion that endothelium-dependent 
vasodilator mechanisms differ among vascular beds. Although 
we did not explore the mechanism responsible for the differ- 
ence in this study, it is plausible to speculate that the mecha- 
nism may be related to the different stages of vascular disease 
process between the coronary and forearm vasculaturc, bc- 
cause it is conceivable that structural changes may bc less in 
forearm vasculaturc than in Loronaty vasculature. 
Our results also suggest that the mechanism responsible for 
the impaired acctylcholine-induced vasodilation of coronary 
and peripheral microcircuhttion in patients with coronary 
artery disease and hypertension may not be related to limited 
availability of t_-aryininc. 
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